Chenyang Shi

Director/Miembro de la Junta en GENSCRIPT BIOTECH CORPORATION .

56 años

Consumer Services

Commercial Services

Health Technology

Cargos activos de Chenyang Shi

Empresas	Cargo	Inicio	Fin
GENSCRIPT BIOTECH CORPORATION	Director/Miembro de la Junta	12/04/2024	-
GENSCRIPT BIOTECH CORPORATION	Independent Dir/Board Member	12/04/2024	-

Empresas	Cargo	Inicio	Fin
NuProbe USA, Inc. NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.	Director/Miembro de la Junta	01/01/2016	-
	Director Ejecutivo	01/01/2016	-
	Fundador	01/01/2016	-
	Presidente	01/01/2016	-

Rochester Christian University	Doctorate Degree
University of Science & Technology of China	Undergraduate Degree

Internacional

Estados Unidos	3
China	3

Operativa

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
GENSCRIPT BIOTECH CORPORATION	Health Technology

Empresas privadas	1
NuProbe USA, Inc. NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.	Commercial Services

Empresas privadas

Commercial Services